ʻoihana lāʻau lapaʻau honua | Mākeke 2021

ʻO ka mākeke lāʻau lapaʻau honua, i manaʻo ʻia ma US $ 1.2 Trillion ma 2019, e manaʻo ʻia e hoʻonui i kahi Compounded Annual Growth Rate (CAGR) o 3-6% a i US $ 1.5-1.6 Trillion e 2024.

ʻO ka hapa nui o kēia e alakaʻi ʻia e ka ulu ʻana o ka nui o nā mākeke pharmerging a me ka hoʻomaka ʻana o nā huahana hou kūikawā kiʻekiʻe i nā mākeke hoʻomohala. Eia nō naʻe, ʻo ka paʻa ʻana o ke kumukūʻai a me ka pau ʻana o ka patent i nā mākeke hoʻomohala hiki ke hoʻopau i kēia ulu.

ʻO ka mākeke lāʻau lapaʻau honua i ka ulu ʻana
ʻO ka mākeke lāʻau lapaʻau honua i ka ulu ʻana

ʻO Outlook, nā hopena a me nā ʻano e puka mai ana

E noho mau ka US a me nā mākeke kūʻai i nā mea nui o ka ʻoihana lāʻau lapaʻau honua - ʻo ka mea mua ma muli o ka nui, a ʻo ka hope ma muli o ko lākou ulu ʻana.

Kuhi ʻia ka hoʻolimalima lāʻau lapaʻau ma US e ulu ma 3-6% CAGR ma waena o 2019 a me 2024, a hiki i ka US $ 605-635 Billion e 2024, ʻoiai ke hoʻolilo ʻana i nā mākeke kūʻai, me Kina, e ulu paha ma 5-8% CAGR. i ka US$475-505 Billion ma 2024.

Ka ulu ʻana o ka lāʻau lapaʻau honua

E lilo kēia mau ʻāina ʻelua i mea kōkua nui i ka ulu lāʻau lapaʻau honua.


• ʻO ka hoʻolilo lāʻau lapaʻau ma nā mākeke ʻelima komohana ʻEulopa (WE5) e ulu paha ma 3-6% CAGR ma waena o 2019 a me 2024 a hiki i ka US $ 210‑240 Billion e 2024.
• Ua manaʻo ʻia ka ulu ʻana o ka mākeke lāʻau lapaʻau o Kina ma 142-5% CAGR i ka US $8‑165 Billion e 195, ʻoiai ʻo ka ulu ʻana o ka hoʻolilo lāʻau lapaʻau o Iapana e hoʻomau mau ʻia ma ka US $2024‑88 Billion e 98.

ʻOihana Laʻau Lapaʻau honua

Kūleʻa mea lāʻau lapaʻau hui e hoʻomau i ka ʻimi ʻana i nā ala lapaʻau hou a me nā ʻenehana, e like me nā huahana holomua e hoʻoponopono i nā pono o ka maʻi i kūpono ʻole.

ʻO kā lākou noiʻi koʻikoʻi koʻikoʻi ʻo ka immunology, oncology, biologics a me nā cell and gene therapies.
• Global R&D lilo ua manaoia e ulu ma ka CAGR o 3% e 2024, haʻahaʻa ma mua o ka 4.2% ma waena o 2010 a me 2018, he hapa i alakaʻi ʻia e nā ʻoihana e nānā i nā hōʻailona liʻiliʻi, me nā kumukūʻai hoʻomohala haʻahaʻa.
• ʻO nā ʻenehana kikohoʻe ka ikaika hoʻololi no ka mālama ola kino. ʻO ka hoʻomau ʻana no ka naʻauao akamai a me ka aʻo ʻana i ka mīkini e lawe i nā hopena koʻikoʻi i loko o ka ʻepekema data no ka loiloi ʻana i ka hoʻoholo ʻana, ka mālama pono ʻana i ka pilikino o ka maʻi, a me ka hoʻohana pono ʻana a me ka hoʻokele ʻana i nā pūʻulu ʻikepili ākea a paʻakikī.
• Ke hoʻohana nui ʻia nei nā ʻenehana kikohoʻe no ka hoʻopili ʻana i ka maʻi-i-kauka i kēia manawa no ka mea ʻaʻole hiki ke kūkākūkā maka a me ke alo ma muli o COVID-19. Ke ʻike ʻia nei inā e hoʻomau ʻia kēia ʻano i ka wā post COVID-19 pū kekahi.
• ʻO kekahi o nā kumu hilinaʻi nui e hoʻopuka i nā ʻike maʻi koʻikoʻi ʻo ia ka ʻikepili genomic, no ka mea e hoʻomaʻamaʻa i ka hoʻomaopopo ʻana i ke kumu genetic o nā maʻi a me ka mālama ʻana i nā maʻi hoʻokele genetically me nā lāʻau lapaʻau i hoʻokumu ʻia.
• E hoʻomau ka poʻe uku (nā hui hoʻolimalima) i ka hoʻemi ʻana i nā kumukūʻai. ʻOiai ke hoʻokō ʻia nei nā hana e hoʻomaikaʻi ai i ka loaʻa ʻana o nā huahana hou i ke kumu kūʻai nui, ʻoi aku ka kiʻekiʻe o ka hoʻopaʻa ʻana i ke kumukūʻai ma nā papa kuhikuhi o nā mea uku ma nā mākeke i kūkulu ʻia. E kōkua kēia i ka hoʻohaʻahaʻa mālie ʻana i ka ulu holoʻokoʻa o mea lāʻau lapaʻau hui, ʻoi aku ma nā mākeke i kūkulu ʻia.
• Ma nā mākeke hoʻomohala ʻia, e loaʻa ana nā koho lapaʻau hou no nā maʻi kakaʻikahi a me ka maʻi kanesa, ʻoiai hiki ke kūʻai ʻia ma ke kumukūʻai kiʻekiʻe i nā maʻi ma kekahi mau ʻāina. Ma nā mākeke kūʻai kūʻai, ʻoi aku ka nui o ka loaʻa ʻana o nā koho lapaʻau a me ka hoʻonui ʻana i ka hoʻolilo ʻana i nā lāʻau lapaʻau e hopena maikaʻi i nā hopena olakino.

heluhelu mai o More  ʻO 10 ʻO nā ʻoihana Pharma Generic ma ka honua
ʻO ka mākeke lāʻau lapaʻau honua 2024
ʻO ka mākeke lāʻau lapaʻau honua 2024

Nā Mākeke i kūkulu ʻia

Ua ulu ka hoʻolimalima lāʻau lapaʻau i nā mākeke i hoʻomohala ʻia ma ~ 4% CAGR ma waena o 2014-19, a ua manaʻo ʻia e ulu ma kahi o 2-5% CAGR a hiki i ka US $ 985-1015 Billion e 2024. Ua helu kēia mau mākeke no ~ 66% o ka lāʻau lapaʻau honua.
hoʻolilo i ka makahiki 2019, a ke manaʻo ʻia nei e helu no ~ 63% o ka hoʻolimalima honua e 2024.

Mākeke Lapaʻau USA

Ke hoʻomau nei ʻo USA i ka mākeke lāʻau lapaʻau nui loa, helu mahina no ~ 41% o ka hoʻolilo lāʻau lapaʻau honua. Ua hoʻopaʻa ʻia ʻo ~ 4% CAGR no 2014-19 a manaʻo ʻia e ulu ma 3-6% CAGR i US $ 605-635 Billion e 2024.

E alakaʻi nui ʻia ka ulu ʻana e ka hoʻomohala ʻana a me ka hoʻokuʻu ʻana i nā lāʻau lapaʻau kūikawā hou, akā e hoʻohaʻahaʻa ʻia e ka pau ʻana o nā patent o nā lāʻau lapaʻau e kū nei a me nā kumu hoʻēmi kumu kūʻai e nā mea uku.

Nā mākeke ʻEulopa Komohana (WE5).

ʻO ka hoʻolimalima lāʻau lapaʻau ma nā mākeke ʻelima Western European (WE5) i manaʻo ʻia e ulu ma kahi o 3-6% CAGR i US $ 210-240 Billion e 2024. ʻO ka hoʻolaha ʻana o nā huahana kūikawā hou e hoʻoikaika i kēia ulu.

ʻO nā kumu kūʻai kumu kūʻai alakaʻi ʻia e ke aupuni e hoʻomaikaʻi i ke komo ʻana o ka poʻe maʻi e hana ma ke ʻano he
ka ikaika hoʻohālikelike i kēia ulu.

Makeke lāʻau lapaʻau Iapana

Manaʻo ka mākeke lāʻau lapaʻau Iapana e hoʻopaʻa i ka ulu pālahalaha ma waena o 2019-24 a ma kahi o US $ 88 Billion.

ʻO nā kulekele aupuni maikaʻi ka hopena i ka piʻi ʻana o ka hoʻohana ʻana i nā generics, i hui pū ʻia me ka hoʻololi ʻana i nā kumu kūʻai i lalo no nā huahana lāʻau. E maʻalahi kēia i ka mālama ʻana i ka hoʻolimalima mālama olakino, e hoʻohaʻahaʻa i ka ulu ʻana o ka ʻoihana ʻoiai nā huahana hou.

Nā mākeke i kūkulu ʻia - Hoʻolilo lāʻau lapaʻau
Nā mākeke i kūkulu ʻia - Hoʻolilo lāʻau lapaʻau

Makeke Pharmerging

Ua ulu ka hoʻolimalima lāʻau lapaʻau i nā mākeke lāʻau lapaʻau ma ~ 7% CAGR i ka makahiki 2014-19 a i US $ 358 Billion. Loaʻa iā ʻoe nā mākeke ~ 28% o ka hoʻolilo honua ma 2019 a
Manaʻo ʻia e helu no 30-31% o ka hoʻolilo ʻana e 2024.

heluhelu mai o More  ʻO nā hui 10 Kina Biotech [Pharma] kiʻekiʻe

Ke hoʻomau nei nā mākeke Pharmerging i ka hoʻopaʻa inoa ʻana i ka ulu wikiwiki ma mua o nā mākeke hoʻomohala, me kahi 5-8% CAGR ma 2024, ʻoiai ʻoi aku ka haʻahaʻa ma mua o ka 7% CAGR i hoʻopaʻa ʻia i ka makahiki 2014-19.

E hoʻoikaika ʻia ka ulu ʻana i nā mākeke pharmerging e nā puke kiʻekiʻe no ka branded a maʻemaʻe nōhie nā lāʻau lapaʻau i alakaʻi ʻia e ka hoʻonui ʻana i ke komo ʻana i waena o ka lehulehu. Kekahi mau mea hou loa
Hiki ke hoʻokuʻu ʻia nā lāʻau lapaʻau hou ma kēia mau mākeke, akā no ke kumukūʻai kiʻekiʻe o ia mau huahana, hiki ke kaupalena ʻia ka lawe ʻana.

ʻoihana lāʻau lapaʻau India

ʻO ka ʻoihana lāʻau lapaʻau India kekahi o ka ulu wikiwiki loa, ma ka honua holoʻokoʻa, a ʻo ka mea hoʻopuka nui loa o nā lāʻau lapaʻau maʻamau e ka nui. Ua hoʻopaʻa ʻia ka mākeke formulations home ma India ~ 9.5% CAGR i ka makahiki 2014-19 a hiki i ka US $ 22 Billion a ke manaʻo ʻia e ulu ma 8-11% CAGR i US $ 31-35 Billion e 2024.

Hoʻonohonoho kūʻokoʻa ʻo India ma ke ʻano he mea hoʻolako koʻikoʻi o nā lāʻau lapaʻau ma ke ʻano o ka loea kemika, nā kumukūʻai haʻahaʻa o nā limahana a me ka hiki ke hana i ka maikaʻi.
nā lāʻau lapaʻau e like me nā kūlana hoʻoponopono honua. E hoʻomau ia i mea pāʻani koʻikoʻi i ka mākeke generics honua.

Nā Laʻau Laʻau Kūikawā

ʻO ka ulu nui ʻana o nā lāʻau lapaʻau kūikawā he mea hoʻokele ulu mau i ka hoʻolimalima lāʻau lapaʻau honua i nā makahiki i hala aku nei, ʻoi aku hoʻi i nā mākeke hoʻomohala.
Hoʻohana ʻia nā lāʻau lapaʻau kūikawā i ka mālama ʻana i nā maʻi maʻi maʻi, paʻakikī a i ʻole nā ​​​​maʻi maʻi, e koi ana i ka noiʻi holomua a me ka hana hou (nā lāʻau lapaʻau no nā maʻi maʻi maʻi,
nā lāʻau lapaʻau immunology, nā maʻi maʻi makua ʻole, ka gene a me ka cell therapy, a me nā mea ʻē aʻe).

Ua hoʻololi nui kēia mau huahana i nā hopena maʻi. Hāʻawi ʻia i ke kumu kūʻai kiʻekiʻe, ʻo ka hapa nui o ka lawe ʻana o kēia mau huahana i nā mākeke me nā ʻōnaehana hoʻihoʻi ikaika.

I nā makahiki he ʻumi, mai 2009 a 2019, ua piʻi ka hāʻawi ʻana o nā huahana kūikawā i ka hoʻolimalima lāʻau lapaʻau honua mai 21% a 36%. Hoʻohui, i nā mākeke hoʻomohala, ua hoʻonui ʻia ka hāʻawi mai 23% a i 44%, ʻoiai ma nā mākeke pharmerging, ua ulu ia mai 11% a 14% e 2019.

heluhelu mai o More  ʻO 10 ʻoihana lāʻau lapaʻau kiʻekiʻe ma ka honua 2022

ʻOi aku ka lohi o ka lawe ʻana i kēia mau huahana ma nā mākeke kūʻai ma muli o ka nele a i ʻole ka lawa ʻole o ka ʻinikua ʻinikua no ka lehulehu. Manaʻo ʻia ka ulu ʻana o ka ulu ʻana e like me ka hoʻomohala ʻana o nā huahana kūikawā a kūʻai ʻia no nā pono olakino ʻole.

Manaʻo paha lākou no ka 40% o ka hoʻolimalima lāʻau lapaʻau honua e 2024, me ka wikiwiki o ka ulu ʻana i manaʻo ʻia ma nā mākeke i kūkulu ʻia, kahi e hiki ai ke hāʻawi i nā huahana kūikawā i ka 50% e 2024.

ʻO ka Oncology, nā maʻi autoimmune a me ka immunology nā ʻāpana nui i ka lewa, a e mau paha nā mea hoʻokele ulu nui i ka manawa 2019-2024.

Nā Mea Hana Lapaʻau Hoʻoikaika (API)

Kuhi ʻia ka mākeke API honua e hōʻea ma kahi o US $ 232 Billion e 2024, e ulu ana ma kahi CAGR ma kahi o 6%. ʻO kekahi mau mea nui e alakaʻi nei i kēia ka spike o nā maʻi maʻi a me nā maʻi maʻi mau.

Ke koi ʻia nei e ka hoʻohana ʻana no ka hana ʻana i nā formulations i ka
anti-infectives, diabetes, cardiovascular, analgesics a me nā ʻāpana hoʻomalu ʻeha. ʻO kekahi kumu ʻē aʻe ka piʻi ʻana o ka hoʻohana ʻana o nā API i loko o nā hoʻolālā hou e alualu i nā niche therapies e like me immunology, oncology, biologics a me nā lāʻau makua ʻole.

Ka mālama ola kino

ʻAʻole koi nā huahana olakino o nā mea kūʻai aku i ka lāʻau lapaʻau mai nā limahana mālama olakino a hiki ke kūʻai ʻia ma Over The Counter (OTC) mai kahi hale kūʻai lāʻau. ʻO ka nui o ka mākeke huahana olakino OTC honua ma kahi o US $ 141.5 biliona no 2019, e hoʻopaʻa ana i ka ulu ʻana o 3.9% ma luna o 2018.

Kuhi ʻia e ulu ma 4.3% CAGR a hiki i ~ US $ 175 Billion e 2024. ʻO ka piʻi ʻana o ka loaʻa kālā o nā mea kūʻai aku a me ka hoʻolilo ʻana i ka mālama olakino a me nā huahana olakino nā kumu nui, e hoʻoulu ai i ka ulu ʻana o ka mākeke honua o nā huahana olakino OTC.

Manaʻo ka poʻe maʻi i ʻike i kēia lā i ka lawe ʻana i nā hoʻoholo olakino maikaʻi aʻe a ke hana nei lākou i ka hoʻokele olakino maikaʻi ma o nā mea hana kikohoʻe. Leveraging
ke komo ʻole i ka ʻike, ke ulu nei ka mea kūʻai aku mana, e alakaʻi ana i ka hana ʻana i nā ʻāpana mākeke hou a me nā hiʻohiʻona hou o ka mālama olakino.

Nāʻike e pili ana

E haʻalele i kahi REPLY

Eʻoluʻolu e kau i kāu manaʻo!
Eʻoluʻolu e kau i kou inoa maʻaneʻi